SCALA TL
Spineart SA · Decision date Aug 20, 2026
What did the FDA decide?
FDA records K261049 as a 510(k) premarket notification, with a decision dated Aug 20, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Aug 20, 2026
Regulatory record facts
- Identifier
- K261049
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Spineart SA
- Product code
- MAX
- Decision code
- SESE
- Decision date
- Aug 20, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Intervertebral Fusion Device With Bone Graft, Lumbar.
- Applicant
- Spineart SA
- Product code
- MAX
- FDA device class
- 2
FDA decision timeline
K261049 received
Application receipt date recorded by FDA.
K261049 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MAX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Solco Biomedical Company India Private Limited | 510(k) clearance | Nov 6, 2026 | FDA | |
Symmetrix PX Spinal SystemK262572 | MEDTRONIC SOFAMOR DANEK USA, INC. | 510(k) clearance | Oct 29, 2026 | FDA |
| Alphatec Spine, Inc. | 510(k) clearance | Oct 21, 2026 | FDA | |
TruLift Expandable SystemK261430 | Life Spine, Inc. | 510(k) clearance | Jul 28, 2026 | FDA |
| MEDTRONIC SOFAMOR DANEK USA, INC. | 510(k) clearance | Jul 17, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Spineart SA
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Plan-Les-Ouates
Sources and methodology
- Original FDA record: K261049
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

